You are here: Home » News-CM » Companies » Results
Business Standard

Beryl Drugs standalone net profit declines 35.71% in the December 2019 quarter

Capital Market 

Sales decline 26.47% to Rs 2.25 crore

Net profit of Beryl Drugs declined 35.71% to Rs 0.09 crore in the quarter ended December 2019 as against Rs 0.14 crore during the previous quarter ended December 2018. Sales declined 26.47% to Rs 2.25 crore in the quarter ended December 2019 as against Rs 3.06 crore during the previous quarter ended December 2018. ParticularsQuarter EndedDec. 2019Dec. 2018% Var.Sales2.253.06 -26 OPM %20.4411.11 -PBDT0.400.27 48 PBT0.200.20 0 NP0.090.14 -36

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Thu, February 13 2020. 10:38 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU